Patent · US Active

Composition that comprises at least one oxime and its use in therapeutics

US8604066B2 · kind B2 · utility

2Cited by

1References

14Claims

0Family size

Assignee

SERB · FR

Inventors

Frédéric Baud · Clermont-Ferrand, FR
Pascal HOUZE · Beauchamp, FR
Maya KAYOUKA · Paris, FR

Key dates

Filing date	Sep 28, 2011
Grant date	Dec 10, 2013
Priority date	—
Expiry date	Nov 16, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P11/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A medication, a pharmaceutical composition, and method for the treatment of respiratory poisoning in animals and humans caused by organophosphorus compounds, whereby said medication and said pharmaceutical composition comprise at least one oxime and one blocker of organic cation transporters (OCT).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.